HNRNPA2B1 and breast cancer: For example, hnRNPA2/B1 alters Bcl-x AS, increasing the Bcl-xL (long) anti-apoptotic splicing isoform, which induces breast cancer cell proliferation and reduces sensitivity to doxorubicin [140].